CIK 0001933414 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Mineralys Therapeutics, Inc.
Sign in to watch- Ticker
- MLYS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 841966887
- Phone
- (888) 378-6240
- Business address
- 150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,403,032
- in 5 filings, $2.4M under 10b5-1 plans
Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 62 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-05 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −10,121 | 6,250 | ||
| 2026-01-05 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −26,069 | 134,584 | ||
| 2026-01-05 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −53,630 | 30,388 | ||
| 2026-01-05 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −67,473 | 108,334 | ||
| 2026-01-02 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +10,053 | $1.08 | $11K | 81,888 |
| 2026-01-02 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +3,629 | $15.44 | $56K | 85,517 |
| 2026-01-02 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +9,347 | $10.20 | $95K | 94,864 |
| 2026-01-02 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +20,168 | $16.00 | $323K | 115,032 |
| 2026-01-02 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +24,193 | $14.25 | $345K | 139,225 |
| 2026-01-02 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −70,037 | $35.87 | $2.5M | 69,188 |
| 2026-01-02 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −10,053 | 72,478 | ||
| 2026-01-02 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −3,629 | 16,371 | ||
| 2026-01-02 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −9,347 | 160,653 | ||
| 2026-01-02 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −20,168 | 84,018 | ||
| 2026-01-02 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −24,193 | 175,807 | ||
| 2025-11-21 | Congleton Jon Chief Executive Officer | Option exercise | +24,082 | $0.54 | $13K | 655,387 |
| 2025-11-21 | Congleton Jon Chief Executive Officer | Option exercise · Stock Option | −24,082 | 0 | ||
| 2025-11-20 | Slingsby Brian Taylor Director | Sale | −1,000,000 | $43.35 | $43.4M | 7,903,838 |
| 2025-11-13 | Karydas Daphne Director | Option exercise | +15,000 | $10.20 | $153K | 15,000 |
| 2025-11-13 | Karydas Daphne Director | Sale | −10,115 | $45.81 | $463K | 4,885 |
Page 10 of 17 · 321 trades